Read the latest positive news, breakthroughs, and inspiring stories about cholesterol, curated daily by BrightWire.
Scientists developed a DNA-based therapy that slashed cholesterol levels nearly in half with just one injection in mice. The treatment offers hope for millions who struggle with statins or need better options to prevent heart disease.
A groundbreaking 15-year study tracking over 132,000 people found that cholesterol-lowering statins can reduce dementia risk by up to 15%. The earlier people start taking these inexpensive, widely available drugs, the better their chances of avoiding the disease.
The FDA just approved the first cholesterol pill that works like an injection, lowering bad cholesterol by up to 60% without needles. For millions who struggle with high cholesterol, this breakthrough offers a simpler path to protecting their hearts.
The FDA just approved the first once-daily pill that slashes bad cholesterol by nearly 60%, offering hope to millions of Americans who struggle with high cholesterol. Unlike previous treatments that required injections, this breakthrough comes in a simple pill you can take at home.
A groundbreaking once-daily pill just won FDA approval that drops dangerous cholesterol to levels statins can't touch, and it costs a fraction of existing alternatives. For millions at risk of heart disease, this could be the game changer doctors have been waiting for.
Updated cholesterol guidelines now recommend earlier screening and personalized treatment plans that could prevent heart attacks and strokes before they happen. The changes focus on catching risks in your 30s instead of waiting until middle age.
)
A single gene-editing treatment could replace daily cholesterol pills for millions, after early trials showed one infusion cut dangerous LDL levels by 62% for up to 18 months. Scientists used CRISPR technology to modify how the body naturally clears cholesterol from blood.
Scientists are testing a one-time treatment that could protect people from heart disease forever. Early results show dramatic drops in cholesterol after a single infusion.
Scientists tested a one-time gene therapy that lowered cholesterol up to 62% in patients, potentially replacing daily pills and injections with a single treatment. The breakthrough could transform how millions manage heart disease risk.
A new gene-editing treatment could lower bad cholesterol permanently with just one infusion, eliminating the need for daily medication. Early trial results show a 62% drop in LDL cholesterol that's lasted up to 18 months.
A one-time gene-editing treatment lowered dangerous cholesterol levels by 62% in early human trials, offering hope for millions who struggle with heart disease prevention. The therapy produced no serious side effects, marking a major safety milestone.
A one-time gene-editing treatment slashed bad cholesterol by 62% in early human trials, offering hope for millions who struggle with heart disease prevention. Eli Lilly's breakthrough therapy showed no serious side effects in the study.